Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sabina Sperandio is active.

Publication


Featured researches published by Sabina Sperandio.


Cell Death & Differentiation | 2004

Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix

Sabina Sperandio; K Poksay; I. de Belle; M J Lafuente; B Liu; J Nasir; Dale E. Bredesen

AbstarctProgrammed cell death (pcd) may take the form of apoptotic or nonapoptotic pcd. Whereas cysteine aspartyl-specific proteases (caspases) mediate apoptosis, the mediators of nonapoptotic cell death programs are much less well characterized. Here, we report that paraptosis, an alternative, nonapoptotic cell death program that may be induced by the insulin-like growth factor I receptor (among other inducers), is mediated by mitogen-activated protein kinases (MAPKs) and inhibited by AIP-1/Alix. The inhibition by AIP-1/Alix is specific for paraptosis since apoptosis was not inhibited. Caspases were not activated in this paradigm, nor were caspase inhibitors effective in blocking cell death. However, insulin-like growth factor I receptor (IGFIR)-induced paraptosis was inhibited by MEK-2-specific inhibitors and by antisense oligonucleotides directed against c-jun N-terminal kinase-1 (JNK-1). These results suggest that IGFIR-induced paraptosis is mediated by MAPKs, and inhibited by AIP-1/Alix.


Journal of Neuroscience Research | 2000

Dimerization‐dependent block of the proapoptotic effect of P75NTR

James J. L. Wang; Shahrooz Rabizadeh; Andrea Tasinato; Sabina Sperandio; Xin Ye; Michael Green; Nuria Assa-Munt; David M. Spencer; Dale E. Bredesen

The biochemical mechanism by which neurons become dependent on neurotrophins for survival is unknown. We found previously that the common neurotrophin receptor, p75NTR, is a mediator of neurotrophin dependence and that this effect requires a novel type of domain dubbed a neurotrophin dependence domain. We report here that, in contrast to other proapoptotic receptors such as Fas, apoptosis induction by p75NTR requires monomerization, with dimerization inhibiting the effect. Blocking the proapoptotic effect of the monomer by dimerization requires a distinct domain that lies at the carboxyterminus of p75NTR. These results define a novel type of domain required for inhibiting apoptosis induction by p75NTR. J. Neurosci. Res. 60:587–593, 2000


Journal of Molecular Neuroscience | 2000

Neurotrophin dependence domain

Shahrooz Rabizadeh; Xin Ye; Sabina Sperandio; James J. L. Wang; H. Michael Ellerby; Christopher C. Giza; Rebecca L. Andrusiak; Harald Frankowski; Yifah Yaron; Nicole Moayeri; Giorgio Rovelli; Christopher J. Evans; Larry L. Butcher; Garry P. Nolan; Nuria Assa-Munt; Dale E. Bredesen

The mechanisms underlying neurotrophin dependence, and cellular dependent states in general, are unknown. We show that a 29 amino acid region in the intracellular domain of the common neurotrophin receptor, p75NTR, is required for the mediation of apoptosis by p75NTR. Furthermore, contrary to results obtained with Fas, monomeric p75NTR is required for apoptosis induction, whereas multimerization inhibits the pro-apoptotic effect. Within the 29-residue domain required for apoptosis induction by p75NTR, a 14-residue region is sufficient as a peptide inducer of apoptosis. This 14-residue peptide requires the positively charged carboxyterminal residues for its effect on cell death, and these same residues are required by the full-length p75NTR. These studies define a novel type of domain that mediates neurotrophin dependence, and suggest that other cellular dependent states may be mediated by proteins displaying similar domains.


Journal of Cellular Biochemistry | 2010

Identification of new modulators and protein alterations in non‐apoptotic programmed cell death

Sabina Sperandio; Karen S. Poksay; Birgit Schilling; Danielle Crippen; Bradford W. Gibson; Dale E. Bredesen

This study describes the first proteomic analysis of paraptosis—a non‐apoptotic form of programmed cell death. As with apoptosis, the first description of paraptosis was based on morphological criteria. Since there are no known markers for paraptosis, the purpose of this study was to dissect changes in the proteome profile occurring during paraptosis. Using one‐ and two‐dimensional SDS–PAGE, Western analysis, and mass spectrometry, we show that during paraptosis, alterations occur mainly in cytoskeletal proteins, signal transduction proteins, mitochondrial proteins, and some metabolic proteins. We also report the identification of: (1) a paraptosis inhibitor, phosphatidylethanolamine binding protein (PEBP‐1), and (2) a candidate mediator of paraptosis, prohibitin. Identification of specific paraptotic changes will ultimately lead to tools to detect this type of programmed cell death in in vivo systems and allow for its further characterization. J. Cell. Biochem. 111: 1401–1412, 2010.


Proceedings of the National Academy of Sciences of the United States of America | 2000

An alternative, nonapoptotic form of programmed cell death

Sabina Sperandio; Ian de Belle; Dale E. Bredesen


Cell Death & Differentiation | 1998

p75NTR and the concept of cellular dependence: seeing how the other half die.

Dale E. Bredesen; Xin Ye; Andrea Tasinato; Sabina Sperandio; James Wang; Nuria Assa-Munt; Shahrooz Rabizadeh


Journal of Biological Chemistry | 2003

Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1).

Veronica Galvan; Anna Logvinova; Sabina Sperandio; Hidenori Ichijo; Dale E. Bredesen


Archive | 2002

Modulators of paraptosis and related methods

Sabina Sperandio; Dale E. Bredesen


Archive | 2002

Cell death programs in neural development and disease

Sabina Sperandio; Ian deBelle; Susana Castro-Obregon; Gabriel del Rio; Dale E. Bredesen; Pak H. Chan


Archive | 2011

TARGET OF EGR1 (TOE1) POLYPEPTIDES FOR INHIBITION OF HIV

Ian de Belle; Sabina Sperandio

Collaboration


Dive into the Sabina Sperandio's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian de Belle

University of California

View shared research outputs
Top Co-Authors

Avatar

Shahrooz Rabizadeh

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar

Anna Logvinova

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar

Birgit Schilling

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar

Bradford W. Gibson

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Danielle Crippen

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar

David M. Spencer

Baylor College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge